UBC researchers are fast becoming international leaders in understanding and eliminating heart and lung diseases.
In collaboration with international partners in healthcare and government, our researchers are crossing divisional and departmental boundaries to develop tests, biomarkers and clinical therapies that will predict, treat and cure two of the world’s leading causes of death.
Spotlight
Yeast found in babies’ guts increases risk of asthma
Microbiologist Brett Finlay will now re-examine the Canadian samples and look for the presence of yeast in the gut of infants.
UBC maps cardiac arrest across metro Vancouver
Neighborhoods with higher proportions of ethnic Chinese residents had a higher frequency of bystanders performing cardiopulmonary resuscitation.
Asthma medication adherence would have dramatic effect on health costs
90 per cent of asthma patients have asthma that could be controlled, but only 25 to 30 per cent of patients are managing their condition properly.
COPD could overwhelm healthcare systems within two decades
Mohsen Sadatsafavi's findings contradict the widespread assumption that the decline in smoking is making COPD a disease of the past.
UBC demonstrates benefits of new monoclonal antibody for asthma
Injections of benralizumab, made by AstraZeneca, led to direct, rapid and near-complete depletion of a type of white blood cell that control the mechanism associated with allergy and asthma.
Synthetic heart valves will help doctors improve surgical skills
A UBC invention co-led by Guy Fradet, Associate Professor, Department of Surgery has made it possible for doctors to vastly improve their bypass surgery techniques without relying on animals.
